Whereas ALT alone demonstrated low predictive power to discriminate steatosis from NASH (AUC: 51%), CatD demonstrated improved the predictive value with an AUC of 84% (Fig. 4B). Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.